(Q40009448)

16 September 2017

Clinical features and prognosis of de novo diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC translocations (English)

1 reference

diffuse large B-cell lymphoma

16 September 2017

1 reference

1 reference

N Niitsu

1

1 reference

16 September 2017

M Okamoto

series ordinal

2

1 reference

16 September 2017

I Miura

series ordinal

3

1 reference

16 September 2017

M Hirano

series ordinal

4

1 reference

16 September 2017

8 January 2009

1 reference

16 September 2017

1 reference

16 September 2017

23

1 reference

16 September 2017

4

1 reference

16 September 2017

777-783

1 reference

https://scigraph.springernature.com/pub.10.1038/leu.2008.344

16 September 2017

0 references

cites work

Prognostic significance of Bcl-6 protein expression in DLBCL treated with CHOP or R-CHOP: a prospective correlative study

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.344

7 January 2021

Translocations involving c-myc and c-myc function

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.344

7 January 2021

The t(14;18) defines a unique subset of diffuse large B-cell lymphoma with a germinal center B-cell gene expression profile

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.344

7 January 2021

The clinical presentation and prognosis of diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC rearrangement.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.344

7 January 2021

Lymphoid neoplasms associated with concurrent t(14;18) and 8q24/c-MYC translocation generally have a poor prognosis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.344

7 January 2021

Multicenter phase II study of the CyclOBEAP (CHOP-like + etoposide and bleomycin) regimen for patients with poor-prognosis aggressive lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.344

7 January 2021

Correlations of chromosome abnormalities with histologic and immunologic characteristics in 49 patients from Akita, Japan with non-Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.344

7 January 2021

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.344

7 January 2021

Revised response criteria for malignant lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.344

7 January 2021

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.344

7 January 2021

Adult B-cell lymphomas with burkitt-like morphology are phenotypically and genotypically heterogeneous with aggressive clinical behavior.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.344

7 January 2021

Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18)

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.344

7 January 2021

The distinction between Burkitt lymphoma and diffuse large B-Cell lymphoma with c-myc rearrangement

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.344

7 January 2021

Comparative immunohistochemical analysis of pediatric Burkitt lymphoma and diffuse large B-cell lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.344

7 January 2021

A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.344

7 January 2021

Molecular diagnosis of Burkitt's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.344

7 January 2021

Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.344

7 January 2021

An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt's lymphoma: results of United Kingdom Lymphoma Group LY06 study

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.344

7 January 2021

Identifiers

DOI

10.1038/LEU.2008.344

1 reference

Dimensions Publication ID

16 September 2017

0 references

1 reference